Valeant Recalls Virazole Due to Microbial Contamination
Valeant Pharmaceuticals is recalling Virazole (ribavirin) inhalation solution due to positive microbial contamination found during stability testing.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves microbial contamination of a sterile inhalation product, which poses a significant risk of serious injury or infection.
Plain-English summary
Valeant Pharmaceuticals North America LLC is recalling 2,428 vials of Virazole (Ribavirin for Inhalation Solution, USP), sterile lyophilized for administration by aerosol inhalation only. The affected product is identified by Lot # 340353F with an expiration date of 10/2018. The product was distributed nationwide and in Australia.
The recall was initiated because Valeant's laboratory observed a positive microbial contamination of the specific lot during testing at the 12-month stability pull. This indicates a non-sterility issue with the product.
Healthcare providers and patients should stop using the affected lot immediately. Consumers should check their medication for the specific lot number and expiration date listed above. If the product matches the recalled lot, it should be returned to the pharmacy or disposed of according to local regulations.
The recalled product
- Product
- Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.
- Manufacturer
- Valeant Pharmaceuticals North America LLC
- Category
- Drug — Inhalation Solution
- Affected units
- 2,428
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 340353F
- Exp 10/2018
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Valeant Pharmaceuticals North America LLC
See all →- ModerateValeant Recalls Cardizem CD Capsules for Dissolution Failures
FDA (Drugs) · 2019-02-20
- ModerateValeant Recalls Cardizem CD Capsules for Dissolution Failures
FDA (Drugs) · 2019-02-20
- LowValeant Recalls Diltiazem HCl Capsules for Dissolution Failures
FDA (Drugs) · 2019-02-20
- ModerateValeant Recalls Cardizem CD Capsules for Dissolution Failures
FDA (Drugs) · 2019-02-20
- ModerateValeant Recalls Cardizem CD Capsules for Dissolution Failures
FDA (Drugs) · 2019-02-20
Same hazard · microbial contamination
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
- HighMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15